nodes	percent_of_prediction	percent_of_DWPC	metapath
Itraconazole—ABCB1—Lisinopril—systemic scleroderma	0.0862	0.189	CbGbCtD
Itraconazole—CYP3A5—Mycophenolate mofetil—systemic scleroderma	0.0781	0.171	CbGbCtD
Itraconazole—ABCB1—Captopril—systemic scleroderma	0.0645	0.141	CbGbCtD
Itraconazole—CYP2D6—Captopril—systemic scleroderma	0.0608	0.133	CbGbCtD
Itraconazole—ABCB1—Mycophenolate mofetil—systemic scleroderma	0.0508	0.111	CbGbCtD
Itraconazole—ABCB1—Prednisone—systemic scleroderma	0.0406	0.089	CbGbCtD
Itraconazole—CYP3A4—Mycophenolate mofetil—systemic scleroderma	0.0304	0.0667	CbGbCtD
Itraconazole—CYP3A4—Prednisone—systemic scleroderma	0.0243	0.0533	CbGbCtD
Itraconazole—ABCB1—Methotrexate—systemic scleroderma	0.0204	0.0447	CbGbCtD
Itraconazole—Loss of consciousness—Mycophenolate mofetil—systemic scleroderma	0.000289	0.000532	CcSEcCtD
Itraconazole—Hyperglycaemia—Prednisone—systemic scleroderma	0.000289	0.000531	CcSEcCtD
Itraconazole—Cough—Mycophenolate mofetil—systemic scleroderma	0.000287	0.000528	CcSEcCtD
Itraconazole—Hypotension—Lisinopril—systemic scleroderma	0.000286	0.000527	CcSEcCtD
Itraconazole—Dizziness—Captopril—systemic scleroderma	0.000286	0.000526	CcSEcCtD
Itraconazole—Liver function test abnormal—Methotrexate—systemic scleroderma	0.000286	0.000525	CcSEcCtD
Itraconazole—Depression—Prednisone—systemic scleroderma	0.000285	0.000523	CcSEcCtD
Itraconazole—Hypertension—Mycophenolate mofetil—systemic scleroderma	0.000284	0.000522	CcSEcCtD
Itraconazole—Urticaria—Leflunomide—systemic scleroderma	0.000283	0.000521	CcSEcCtD
Itraconazole—Abdominal pain—Leflunomide—systemic scleroderma	0.000282	0.000518	CcSEcCtD
Itraconazole—Body temperature increased—Leflunomide—systemic scleroderma	0.000282	0.000518	CcSEcCtD
Itraconazole—Feeling abnormal—Mycophenolic acid—systemic scleroderma	0.00028	0.000516	CcSEcCtD
Itraconazole—Chest pain—Mycophenolate mofetil—systemic scleroderma	0.00028	0.000515	CcSEcCtD
Itraconazole—Arthralgia—Mycophenolate mofetil—systemic scleroderma	0.00028	0.000515	CcSEcCtD
Itraconazole—Myalgia—Mycophenolate mofetil—systemic scleroderma	0.00028	0.000515	CcSEcCtD
Itraconazole—Neuropathy peripheral—Prednisone—systemic scleroderma	0.00028	0.000514	CcSEcCtD
Itraconazole—Breast disorder—Methotrexate—systemic scleroderma	0.00028	0.000514	CcSEcCtD
Itraconazole—Musculoskeletal discomfort—Lisinopril—systemic scleroderma	0.000279	0.000513	CcSEcCtD
Itraconazole—Anxiety—Mycophenolate mofetil—systemic scleroderma	0.000279	0.000513	CcSEcCtD
Itraconazole—Toxic epidermal necrolysis—Methotrexate—systemic scleroderma	0.000279	0.000512	CcSEcCtD
Itraconazole—Hypersensitivity—Azathioprine—systemic scleroderma	0.000278	0.000512	CcSEcCtD
Itraconazole—Gastrointestinal pain—Mycophenolic acid—systemic scleroderma	0.000278	0.000512	CcSEcCtD
Itraconazole—Unspecified disorder of skin and subcutaneous tissue—Mycophenolate mofetil—systemic scleroderma	0.000278	0.000511	CcSEcCtD
Itraconazole—Insomnia—Lisinopril—systemic scleroderma	0.000277	0.00051	CcSEcCtD
Itraconazole—Discomfort—Mycophenolate mofetil—systemic scleroderma	0.000277	0.000509	CcSEcCtD
Itraconazole—Paraesthesia—Lisinopril—systemic scleroderma	0.000275	0.000506	CcSEcCtD
Itraconazole—Vomiting—Captopril—systemic scleroderma	0.000275	0.000506	CcSEcCtD
Itraconazole—Dyspnoea—Lisinopril—systemic scleroderma	0.000273	0.000502	CcSEcCtD
Itraconazole—Rash—Captopril—systemic scleroderma	0.000273	0.000502	CcSEcCtD
Itraconazole—Dermatitis—Captopril—systemic scleroderma	0.000273	0.000501	CcSEcCtD
Itraconazole—Somnolence—Lisinopril—systemic scleroderma	0.000272	0.000501	CcSEcCtD
Itraconazole—Headache—Captopril—systemic scleroderma	0.000271	0.000498	CcSEcCtD
Itraconazole—Confusional state—Mycophenolate mofetil—systemic scleroderma	0.000271	0.000498	CcSEcCtD
Itraconazole—Dyspepsia—Lisinopril—systemic scleroderma	0.00027	0.000496	CcSEcCtD
Itraconazole—Abdominal pain—Mycophenolic acid—systemic scleroderma	0.000269	0.000495	CcSEcCtD
Itraconazole—Body temperature increased—Mycophenolic acid—systemic scleroderma	0.000269	0.000495	CcSEcCtD
Itraconazole—Oedema—Mycophenolate mofetil—systemic scleroderma	0.000269	0.000494	CcSEcCtD
Itraconazole—Anaphylactic shock—Mycophenolate mofetil—systemic scleroderma	0.000269	0.000494	CcSEcCtD
Itraconazole—Infection—Mycophenolate mofetil—systemic scleroderma	0.000267	0.000491	CcSEcCtD
Itraconazole—Decreased appetite—Lisinopril—systemic scleroderma	0.000266	0.00049	CcSEcCtD
Itraconazole—Gastrointestinal disorder—Lisinopril—systemic scleroderma	0.000265	0.000486	CcSEcCtD
Itraconazole—Fatigue—Lisinopril—systemic scleroderma	0.000264	0.000486	CcSEcCtD
Itraconazole—Shock—Mycophenolate mofetil—systemic scleroderma	0.000264	0.000486	CcSEcCtD
Itraconazole—Nervous system disorder—Mycophenolate mofetil—systemic scleroderma	0.000263	0.000484	CcSEcCtD
Itraconazole—Thrombocytopenia—Mycophenolate mofetil—systemic scleroderma	0.000263	0.000483	CcSEcCtD
Itraconazole—Hypersensitivity—Leflunomide—systemic scleroderma	0.000263	0.000483	CcSEcCtD
Itraconazole—Pancreatitis—Methotrexate—systemic scleroderma	0.000262	0.000482	CcSEcCtD
Itraconazole—Pain—Lisinopril—systemic scleroderma	0.000262	0.000482	CcSEcCtD
Itraconazole—Constipation—Lisinopril—systemic scleroderma	0.000262	0.000482	CcSEcCtD
Itraconazole—Tachycardia—Mycophenolate mofetil—systemic scleroderma	0.000262	0.000482	CcSEcCtD
Itraconazole—Skin disorder—Mycophenolate mofetil—systemic scleroderma	0.000261	0.00048	CcSEcCtD
Itraconazole—Hyperhidrosis—Mycophenolate mofetil—systemic scleroderma	0.00026	0.000477	CcSEcCtD
Itraconazole—Diarrhoea—Azathioprine—systemic scleroderma	0.000258	0.000475	CcSEcCtD
Itraconazole—Nausea—Captopril—systemic scleroderma	0.000257	0.000473	CcSEcCtD
Itraconazole—Abdominal discomfort—Methotrexate—systemic scleroderma	0.000256	0.000472	CcSEcCtD
Itraconazole—Anorexia—Mycophenolate mofetil—systemic scleroderma	0.000256	0.000471	CcSEcCtD
Itraconazole—Asthenia—Leflunomide—systemic scleroderma	0.000256	0.000471	CcSEcCtD
Itraconazole—Feeling abnormal—Lisinopril—systemic scleroderma	0.000253	0.000464	CcSEcCtD
Itraconazole—Pruritus—Leflunomide—systemic scleroderma	0.000252	0.000464	CcSEcCtD
Itraconazole—Connective tissue disorder—Prednisone—systemic scleroderma	0.000252	0.000463	CcSEcCtD
Itraconazole—Hypotension—Mycophenolate mofetil—systemic scleroderma	0.000251	0.000461	CcSEcCtD
Itraconazole—Gastrointestinal pain—Lisinopril—systemic scleroderma	0.000251	0.000461	CcSEcCtD
Itraconazole—Neutropenia—Methotrexate—systemic scleroderma	0.00025	0.00046	CcSEcCtD
Itraconazole—Dizziness—Azathioprine—systemic scleroderma	0.00025	0.000459	CcSEcCtD
Itraconazole—Upper respiratory tract infection—Methotrexate—systemic scleroderma	0.000249	0.000457	CcSEcCtD
Itraconazole—Erectile dysfunction—Methotrexate—systemic scleroderma	0.000246	0.000453	CcSEcCtD
Itraconazole—Musculoskeletal discomfort—Mycophenolate mofetil—systemic scleroderma	0.000245	0.00045	CcSEcCtD
Itraconazole—Photosensitivity reaction—Methotrexate—systemic scleroderma	0.000244	0.000449	CcSEcCtD
Itraconazole—Asthenia—Mycophenolic acid—systemic scleroderma	0.000244	0.000449	CcSEcCtD
Itraconazole—Diarrhoea—Leflunomide—systemic scleroderma	0.000244	0.000449	CcSEcCtD
Itraconazole—Urticaria—Lisinopril—systemic scleroderma	0.000243	0.000448	CcSEcCtD
Itraconazole—Insomnia—Mycophenolate mofetil—systemic scleroderma	0.000243	0.000447	CcSEcCtD
Itraconazole—Abdominal pain—Lisinopril—systemic scleroderma	0.000242	0.000445	CcSEcCtD
Itraconazole—Body temperature increased—Lisinopril—systemic scleroderma	0.000242	0.000445	CcSEcCtD
Itraconazole—Paraesthesia—Mycophenolate mofetil—systemic scleroderma	0.000241	0.000443	CcSEcCtD
Itraconazole—Pruritus—Mycophenolic acid—systemic scleroderma	0.000241	0.000443	CcSEcCtD
Itraconazole—Vomiting—Azathioprine—systemic scleroderma	0.00024	0.000442	CcSEcCtD
Itraconazole—Pneumonia—Methotrexate—systemic scleroderma	0.00024	0.000441	CcSEcCtD
Itraconazole—Eye disorder—Prednisone—systemic scleroderma	0.000239	0.00044	CcSEcCtD
Itraconazole—Dyspnoea—Mycophenolate mofetil—systemic scleroderma	0.000239	0.00044	CcSEcCtD
Itraconazole—Somnolence—Mycophenolate mofetil—systemic scleroderma	0.000239	0.000439	CcSEcCtD
Itraconazole—Drowsiness—Methotrexate—systemic scleroderma	0.000239	0.000439	CcSEcCtD
Itraconazole—Infestation—Methotrexate—systemic scleroderma	0.000239	0.000439	CcSEcCtD
Itraconazole—Infestation NOS—Methotrexate—systemic scleroderma	0.000239	0.000439	CcSEcCtD
Itraconazole—Rash—Azathioprine—systemic scleroderma	0.000238	0.000438	CcSEcCtD
Itraconazole—Dermatitis—Azathioprine—systemic scleroderma	0.000238	0.000437	CcSEcCtD
Itraconazole—Depression—Methotrexate—systemic scleroderma	0.000238	0.000437	CcSEcCtD
Itraconazole—Headache—Azathioprine—systemic scleroderma	0.000237	0.000435	CcSEcCtD
Itraconazole—Stevens-Johnson syndrome—Methotrexate—systemic scleroderma	0.000236	0.000435	CcSEcCtD
Itraconazole—Dyspepsia—Mycophenolate mofetil—systemic scleroderma	0.000236	0.000435	CcSEcCtD
Itraconazole—Dizziness—Leflunomide—systemic scleroderma	0.000236	0.000434	CcSEcCtD
Itraconazole—Renal failure—Methotrexate—systemic scleroderma	0.000234	0.000431	CcSEcCtD
Itraconazole—Decreased appetite—Mycophenolate mofetil—systemic scleroderma	0.000233	0.000429	CcSEcCtD
Itraconazole—Diarrhoea—Mycophenolic acid—systemic scleroderma	0.000233	0.000428	CcSEcCtD
Itraconazole—Angiopathy—Prednisone—systemic scleroderma	0.000232	0.000427	CcSEcCtD
Itraconazole—Gastrointestinal disorder—Mycophenolate mofetil—systemic scleroderma	0.000232	0.000426	CcSEcCtD
Itraconazole—Immune system disorder—Prednisone—systemic scleroderma	0.000231	0.000425	CcSEcCtD
Itraconazole—Pain—Mycophenolate mofetil—systemic scleroderma	0.00023	0.000422	CcSEcCtD
Itraconazole—Constipation—Mycophenolate mofetil—systemic scleroderma	0.00023	0.000422	CcSEcCtD
Itraconazole—Arrhythmia—Prednisone—systemic scleroderma	0.000229	0.000421	CcSEcCtD
Itraconazole—Haematuria—Methotrexate—systemic scleroderma	0.000227	0.000418	CcSEcCtD
Itraconazole—Vomiting—Leflunomide—systemic scleroderma	0.000227	0.000417	CcSEcCtD
Itraconazole—Alopecia—Prednisone—systemic scleroderma	0.000226	0.000416	CcSEcCtD
Itraconazole—Hypersensitivity—Lisinopril—systemic scleroderma	0.000226	0.000415	CcSEcCtD
Itraconazole—Hepatobiliary disease—Methotrexate—systemic scleroderma	0.000226	0.000415	CcSEcCtD
Itraconazole—Dizziness—Mycophenolic acid—systemic scleroderma	0.000225	0.000414	CcSEcCtD
Itraconazole—Rash—Leflunomide—systemic scleroderma	0.000225	0.000413	CcSEcCtD
Itraconazole—Dermatitis—Leflunomide—systemic scleroderma	0.000225	0.000413	CcSEcCtD
Itraconazole—Mental disorder—Prednisone—systemic scleroderma	0.000224	0.000413	CcSEcCtD
Itraconazole—Nausea—Azathioprine—systemic scleroderma	0.000224	0.000412	CcSEcCtD
Itraconazole—Headache—Leflunomide—systemic scleroderma	0.000223	0.000411	CcSEcCtD
Itraconazole—Malnutrition—Prednisone—systemic scleroderma	0.000223	0.00041	CcSEcCtD
Itraconazole—Agranulocytosis—Methotrexate—systemic scleroderma	0.000223	0.000409	CcSEcCtD
Itraconazole—Feeling abnormal—Mycophenolate mofetil—systemic scleroderma	0.000221	0.000407	CcSEcCtD
Itraconazole—Asthenia—Lisinopril—systemic scleroderma	0.00022	0.000404	CcSEcCtD
Itraconazole—Gastrointestinal pain—Mycophenolate mofetil—systemic scleroderma	0.00022	0.000404	CcSEcCtD
Itraconazole—Pruritus—Lisinopril—systemic scleroderma	0.000217	0.000399	CcSEcCtD
Itraconazole—Vomiting—Mycophenolic acid—systemic scleroderma	0.000216	0.000398	CcSEcCtD
Itraconazole—Rash—Mycophenolic acid—systemic scleroderma	0.000215	0.000394	CcSEcCtD
Itraconazole—Dermatitis—Mycophenolic acid—systemic scleroderma	0.000214	0.000394	CcSEcCtD
Itraconazole—Hepatitis—Methotrexate—systemic scleroderma	0.000214	0.000394	CcSEcCtD
Itraconazole—Urticaria—Mycophenolate mofetil—systemic scleroderma	0.000213	0.000392	CcSEcCtD
Itraconazole—Headache—Mycophenolic acid—systemic scleroderma	0.000213	0.000392	CcSEcCtD
Itraconazole—Pharyngitis—Methotrexate—systemic scleroderma	0.000213	0.000391	CcSEcCtD
Itraconazole—Abdominal pain—Mycophenolate mofetil—systemic scleroderma	0.000212	0.00039	CcSEcCtD
Itraconazole—Body temperature increased—Mycophenolate mofetil—systemic scleroderma	0.000212	0.00039	CcSEcCtD
Itraconazole—Nausea—Leflunomide—systemic scleroderma	0.000212	0.00039	CcSEcCtD
Itraconazole—Urinary tract disorder—Methotrexate—systemic scleroderma	0.000211	0.000389	CcSEcCtD
Itraconazole—Vision blurred—Prednisone—systemic scleroderma	0.00021	0.000386	CcSEcCtD
Itraconazole—Urethral disorder—Methotrexate—systemic scleroderma	0.00021	0.000386	CcSEcCtD
Itraconazole—Diarrhoea—Lisinopril—systemic scleroderma	0.00021	0.000386	CcSEcCtD
Itraconazole—Ill-defined disorder—Prednisone—systemic scleroderma	0.000207	0.00038	CcSEcCtD
Itraconazole—Visual impairment—Methotrexate—systemic scleroderma	0.000206	0.000379	CcSEcCtD
Itraconazole—Angioedema—Prednisone—systemic scleroderma	0.000204	0.000375	CcSEcCtD
Itraconazole—Dizziness—Lisinopril—systemic scleroderma	0.000203	0.000373	CcSEcCtD
Itraconazole—Erythema multiforme—Methotrexate—systemic scleroderma	0.000202	0.000372	CcSEcCtD
Itraconazole—Nausea—Mycophenolic acid—systemic scleroderma	0.000202	0.000372	CcSEcCtD
Itraconazole—Malaise—Prednisone—systemic scleroderma	0.000201	0.00037	CcSEcCtD
Itraconazole—Vertigo—Prednisone—systemic scleroderma	0.0002	0.000368	CcSEcCtD
Itraconazole—Eye disorder—Methotrexate—systemic scleroderma	0.0002	0.000368	CcSEcCtD
Itraconazole—Syncope—Prednisone—systemic scleroderma	0.0002	0.000368	CcSEcCtD
Itraconazole—Tinnitus—Methotrexate—systemic scleroderma	0.0002	0.000367	CcSEcCtD
Itraconazole—Cardiac disorder—Methotrexate—systemic scleroderma	0.000199	0.000365	CcSEcCtD
Itraconazole—Hypersensitivity—Mycophenolate mofetil—systemic scleroderma	0.000198	0.000364	CcSEcCtD
Itraconazole—Loss of consciousness—Prednisone—systemic scleroderma	0.000196	0.00036	CcSEcCtD
Itraconazole—Vomiting—Lisinopril—systemic scleroderma	0.000195	0.000358	CcSEcCtD
Itraconazole—Angiopathy—Methotrexate—systemic scleroderma	0.000194	0.000357	CcSEcCtD
Itraconazole—Immune system disorder—Methotrexate—systemic scleroderma	0.000193	0.000356	CcSEcCtD
Itraconazole—Rash—Lisinopril—systemic scleroderma	0.000193	0.000355	CcSEcCtD
Itraconazole—Dermatitis—Lisinopril—systemic scleroderma	0.000193	0.000355	CcSEcCtD
Itraconazole—Mediastinal disorder—Methotrexate—systemic scleroderma	0.000193	0.000355	CcSEcCtD
Itraconazole—Asthenia—Mycophenolate mofetil—systemic scleroderma	0.000193	0.000354	CcSEcCtD
Itraconazole—Hypertension—Prednisone—systemic scleroderma	0.000193	0.000354	CcSEcCtD
Itraconazole—Chills—Methotrexate—systemic scleroderma	0.000192	0.000353	CcSEcCtD
Itraconazole—Headache—Lisinopril—systemic scleroderma	0.000192	0.000353	CcSEcCtD
Itraconazole—Pruritus—Mycophenolate mofetil—systemic scleroderma	0.00019	0.000349	CcSEcCtD
Itraconazole—Arthralgia—Prednisone—systemic scleroderma	0.00019	0.000349	CcSEcCtD
Itraconazole—Myalgia—Prednisone—systemic scleroderma	0.00019	0.000349	CcSEcCtD
Itraconazole—Anxiety—Prednisone—systemic scleroderma	0.000189	0.000348	CcSEcCtD
Itraconazole—Alopecia—Methotrexate—systemic scleroderma	0.000189	0.000348	CcSEcCtD
Itraconazole—Unspecified disorder of skin and subcutaneous tissue—Prednisone—systemic scleroderma	0.000189	0.000347	CcSEcCtD
Itraconazole—Discomfort—Prednisone—systemic scleroderma	0.000188	0.000345	CcSEcCtD
Itraconazole—Mental disorder—Methotrexate—systemic scleroderma	0.000188	0.000345	CcSEcCtD
Itraconazole—Malnutrition—Methotrexate—systemic scleroderma	0.000186	0.000343	CcSEcCtD
Itraconazole—Diarrhoea—Mycophenolate mofetil—systemic scleroderma	0.000184	0.000338	CcSEcCtD
Itraconazole—Dysgeusia—Methotrexate—systemic scleroderma	0.000183	0.000336	CcSEcCtD
Itraconazole—Nausea—Lisinopril—systemic scleroderma	0.000182	0.000335	CcSEcCtD
Itraconazole—Anaphylactic shock—Prednisone—systemic scleroderma	0.000182	0.000335	CcSEcCtD
Itraconazole—Oedema—Prednisone—systemic scleroderma	0.000182	0.000335	CcSEcCtD
Itraconazole—Infection—Prednisone—systemic scleroderma	0.000181	0.000332	CcSEcCtD
Itraconazole—Back pain—Methotrexate—systemic scleroderma	0.00018	0.000331	CcSEcCtD
Itraconazole—Shock—Prednisone—systemic scleroderma	0.000179	0.000329	CcSEcCtD
Itraconazole—Nervous system disorder—Prednisone—systemic scleroderma	0.000179	0.000328	CcSEcCtD
Itraconazole—Tachycardia—Prednisone—systemic scleroderma	0.000178	0.000327	CcSEcCtD
Itraconazole—Dizziness—Mycophenolate mofetil—systemic scleroderma	0.000178	0.000326	CcSEcCtD
Itraconazole—Skin disorder—Prednisone—systemic scleroderma	0.000177	0.000325	CcSEcCtD
Itraconazole—Hyperhidrosis—Prednisone—systemic scleroderma	0.000176	0.000324	CcSEcCtD
Itraconazole—Vision blurred—Methotrexate—systemic scleroderma	0.000176	0.000323	CcSEcCtD
Itraconazole—Anorexia—Prednisone—systemic scleroderma	0.000174	0.000319	CcSEcCtD
Itraconazole—Ill-defined disorder—Methotrexate—systemic scleroderma	0.000173	0.000318	CcSEcCtD
Itraconazole—Vomiting—Mycophenolate mofetil—systemic scleroderma	0.000171	0.000314	CcSEcCtD
Itraconazole—Rash—Mycophenolate mofetil—systemic scleroderma	0.000169	0.000311	CcSEcCtD
Itraconazole—Dermatitis—Mycophenolate mofetil—systemic scleroderma	0.000169	0.000311	CcSEcCtD
Itraconazole—Headache—Mycophenolate mofetil—systemic scleroderma	0.000168	0.000309	CcSEcCtD
Itraconazole—Malaise—Methotrexate—systemic scleroderma	0.000168	0.000309	CcSEcCtD
Itraconazole—Vertigo—Methotrexate—systemic scleroderma	0.000167	0.000308	CcSEcCtD
Itraconazole—Leukopenia—Methotrexate—systemic scleroderma	0.000167	0.000307	CcSEcCtD
Itraconazole—Musculoskeletal discomfort—Prednisone—systemic scleroderma	0.000166	0.000305	CcSEcCtD
Itraconazole—Insomnia—Prednisone—systemic scleroderma	0.000165	0.000303	CcSEcCtD
Itraconazole—Paraesthesia—Prednisone—systemic scleroderma	0.000163	0.000301	CcSEcCtD
Itraconazole—Cough—Methotrexate—systemic scleroderma	0.000163	0.000299	CcSEcCtD
Itraconazole—Dyspepsia—Prednisone—systemic scleroderma	0.00016	0.000295	CcSEcCtD
Itraconazole—Nausea—Mycophenolate mofetil—systemic scleroderma	0.00016	0.000293	CcSEcCtD
Itraconazole—Chest pain—Methotrexate—systemic scleroderma	0.000159	0.000292	CcSEcCtD
Itraconazole—Arthralgia—Methotrexate—systemic scleroderma	0.000159	0.000292	CcSEcCtD
Itraconazole—Myalgia—Methotrexate—systemic scleroderma	0.000159	0.000292	CcSEcCtD
Itraconazole—Decreased appetite—Prednisone—systemic scleroderma	0.000158	0.000291	CcSEcCtD
Itraconazole—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—systemic scleroderma	0.000158	0.00029	CcSEcCtD
Itraconazole—Fatigue—Prednisone—systemic scleroderma	0.000157	0.000289	CcSEcCtD
Itraconazole—Discomfort—Methotrexate—systemic scleroderma	0.000157	0.000288	CcSEcCtD
Itraconazole—Constipation—Prednisone—systemic scleroderma	0.000156	0.000286	CcSEcCtD
Itraconazole—Confusional state—Methotrexate—systemic scleroderma	0.000153	0.000282	CcSEcCtD
Itraconazole—Anaphylactic shock—Methotrexate—systemic scleroderma	0.000152	0.00028	CcSEcCtD
Itraconazole—Infection—Methotrexate—systemic scleroderma	0.000151	0.000278	CcSEcCtD
Itraconazole—Feeling abnormal—Prednisone—systemic scleroderma	0.00015	0.000276	CcSEcCtD
Itraconazole—Nervous system disorder—Methotrexate—systemic scleroderma	0.000149	0.000274	CcSEcCtD
Itraconazole—Thrombocytopenia—Methotrexate—systemic scleroderma	0.000149	0.000274	CcSEcCtD
Itraconazole—Gastrointestinal pain—Prednisone—systemic scleroderma	0.000149	0.000274	CcSEcCtD
Itraconazole—Skin disorder—Methotrexate—systemic scleroderma	0.000148	0.000272	CcSEcCtD
Itraconazole—Hyperhidrosis—Methotrexate—systemic scleroderma	0.000147	0.00027	CcSEcCtD
Itraconazole—Anorexia—Methotrexate—systemic scleroderma	0.000145	0.000267	CcSEcCtD
Itraconazole—Urticaria—Prednisone—systemic scleroderma	0.000145	0.000266	CcSEcCtD
Itraconazole—Abdominal pain—Prednisone—systemic scleroderma	0.000144	0.000265	CcSEcCtD
Itraconazole—Body temperature increased—Prednisone—systemic scleroderma	0.000144	0.000265	CcSEcCtD
Itraconazole—Hypotension—Methotrexate—systemic scleroderma	0.000142	0.000261	CcSEcCtD
Itraconazole—Musculoskeletal discomfort—Methotrexate—systemic scleroderma	0.000139	0.000255	CcSEcCtD
Itraconazole—Insomnia—Methotrexate—systemic scleroderma	0.000138	0.000253	CcSEcCtD
Itraconazole—Paraesthesia—Methotrexate—systemic scleroderma	0.000137	0.000251	CcSEcCtD
Itraconazole—Dyspnoea—Methotrexate—systemic scleroderma	0.000136	0.000249	CcSEcCtD
Itraconazole—Somnolence—Methotrexate—systemic scleroderma	0.000135	0.000249	CcSEcCtD
Itraconazole—Hypersensitivity—Prednisone—systemic scleroderma	0.000134	0.000247	CcSEcCtD
Itraconazole—Dyspepsia—Methotrexate—systemic scleroderma	0.000134	0.000246	CcSEcCtD
Itraconazole—Decreased appetite—Methotrexate—systemic scleroderma	0.000132	0.000243	CcSEcCtD
Itraconazole—Gastrointestinal disorder—Methotrexate—systemic scleroderma	0.000131	0.000241	CcSEcCtD
Itraconazole—Fatigue—Methotrexate—systemic scleroderma	0.000131	0.000241	CcSEcCtD
Itraconazole—Asthenia—Prednisone—systemic scleroderma	0.000131	0.00024	CcSEcCtD
Itraconazole—Pain—Methotrexate—systemic scleroderma	0.00013	0.000239	CcSEcCtD
Itraconazole—Pruritus—Prednisone—systemic scleroderma	0.000129	0.000237	CcSEcCtD
Itraconazole—Feeling abnormal—Methotrexate—systemic scleroderma	0.000125	0.00023	CcSEcCtD
Itraconazole—Diarrhoea—Prednisone—systemic scleroderma	0.000125	0.000229	CcSEcCtD
Itraconazole—Gastrointestinal pain—Methotrexate—systemic scleroderma	0.000124	0.000229	CcSEcCtD
Itraconazole—Urticaria—Methotrexate—systemic scleroderma	0.000121	0.000222	CcSEcCtD
Itraconazole—Dizziness—Prednisone—systemic scleroderma	0.00012	0.000221	CcSEcCtD
Itraconazole—Abdominal pain—Methotrexate—systemic scleroderma	0.00012	0.000221	CcSEcCtD
Itraconazole—Body temperature increased—Methotrexate—systemic scleroderma	0.00012	0.000221	CcSEcCtD
Itraconazole—Vomiting—Prednisone—systemic scleroderma	0.000116	0.000213	CcSEcCtD
Itraconazole—Rash—Prednisone—systemic scleroderma	0.000115	0.000211	CcSEcCtD
Itraconazole—Dermatitis—Prednisone—systemic scleroderma	0.000115	0.000211	CcSEcCtD
Itraconazole—Headache—Prednisone—systemic scleroderma	0.000114	0.00021	CcSEcCtD
Itraconazole—Hypersensitivity—Methotrexate—systemic scleroderma	0.000112	0.000206	CcSEcCtD
Itraconazole—Asthenia—Methotrexate—systemic scleroderma	0.000109	0.000201	CcSEcCtD
Itraconazole—Nausea—Prednisone—systemic scleroderma	0.000108	0.000199	CcSEcCtD
Itraconazole—Pruritus—Methotrexate—systemic scleroderma	0.000108	0.000198	CcSEcCtD
Itraconazole—Diarrhoea—Methotrexate—systemic scleroderma	0.000104	0.000191	CcSEcCtD
Itraconazole—Dizziness—Methotrexate—systemic scleroderma	0.000101	0.000185	CcSEcCtD
Itraconazole—Vomiting—Methotrexate—systemic scleroderma	9.67e-05	0.000178	CcSEcCtD
Itraconazole—Rash—Methotrexate—systemic scleroderma	9.59e-05	0.000176	CcSEcCtD
Itraconazole—Dermatitis—Methotrexate—systemic scleroderma	9.58e-05	0.000176	CcSEcCtD
Itraconazole—Headache—Methotrexate—systemic scleroderma	9.53e-05	0.000175	CcSEcCtD
Itraconazole—Nausea—Methotrexate—systemic scleroderma	9.04e-05	0.000166	CcSEcCtD
